Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Renal Failure

  Free Subscription

Articles published in Am J Nephrol

Retrieve available abstracts of 47 articles:
HTML format

Single Articles

    November 2022
  1. TANGRI N, Mathur V, Reaven N, Funk SE, et al
    Relationship between Metabolic Acidosis and Chronic Kidney Disease Progression across Racial and Ethnic Groups: An Observational, Retrospective Cohort Study.
    Am J Nephrol. 2022 Nov 8:1-11. doi: 10.1159/000527036.
    PubMed     Abstract available

  2. SERRANO M, Srivastava A, Buck G, Zhu B, et al
    Dietary Protein and Fiber Affect Gut Microbiome and Treg/Th17 Commitment in Chronic Kidney Disease Mice.
    Am J Nephrol. 2022 Nov 7:1-6. doi: 10.1159/000526957.
    PubMed     Abstract available

  3. QU X, Tong X, Hou X, Zhang J, et al
    Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2022 Nov 7:1-12. doi: 10.1159/000526956.
    PubMed     Abstract available

  4. ALLINOVI M, Bergesio F, Cappelli F, Chiappini MG, et al
    Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease?
    Am J Nephrol. 2022 Nov 7:1-4. doi: 10.1159/000526955.

    October 2022
  5. BURROWS NR, Koyama AK, Choudhury D, Yu W, et al
    Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease.
    Am J Nephrol. 2022 Oct 7:1-11. doi: 10.1159/000526254.
    PubMed     Abstract available

    September 2022
  6. LIU Q, Bai B, Liu F, Chen Y, et al
    Long-Term Trends in Risk Factor Management in Respondents with Chronic Kidney Disease in the USA.
    Am J Nephrol. 2022 Sep 20:1-10. doi: 10.1159/000525733.
    PubMed     Abstract available

    August 2022
  7. XU X, Ma T, Tian X, Li S, et al
    Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study.
    Am J Nephrol. 2022 Aug 17:1-11. doi: 10.1159/000525917.
    PubMed     Abstract available

    July 2022
  8. EINBINDER Y, Perl J, Nacasch N, Bnaya A, et al
    Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
    Am J Nephrol. 2022 Jul 18:1-5. doi: 10.1159/000525309.
    PubMed     Abstract available

    June 2022
  9. THEOFILIS P, Vordoni A, Kalaitzidis RG
    The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
    Am J Nephrol. 2022 Jun 29:1-10. doi: 10.1159/000525441.
    PubMed     Abstract available

  10. LEGENDRE B, Lobbedez T, Couchoud C, Lassalle M, et al
    Switch from Hemodialysis to Peritoneal Dialysis: Does the Time Spent on Hemodialysis Impact Outcomes in Peritoneal Dialysis?
    Am J Nephrol. 2022 Jun 22:1-10. doi: 10.1159/000524960.
    PubMed     Abstract available

  11. VRIST MH, Ostergaard AMH, Langaa SS, Mose FH, et al
    Bone Turnover, Mineralization, and Volume Estimated by 18F-Sodium Fluoride PET/CT and Biomarkers in Chronic Kidney Disease: Mineral and Bone Disorder Compared with Bone Biopsy.
    Am J Nephrol. 2022 Jun 7:1-13. doi: 10.1159/000524961.
    PubMed     Abstract available

    May 2022
  12. WANG K, Qian D, Hu Y, Cheng Y, et al
    Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States.
    Am J Nephrol. 2022 May 24:1-10. doi: 10.1159/000524382.
    PubMed     Abstract available

  13. BISHOP CW, Strugnell SA, Csomor P, Kaiser E, et al
    Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
    Am J Nephrol. 2022 May 12:1-9. doi: 10.1159/000524289.
    PubMed     Abstract available

    April 2022
  14. MURRAY AM, Slinin Y, Tupper DE, Pederson SL, et al
    Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study.
    Am J Nephrol. 2022 Apr 28:1-11. doi: 10.1159/000524166.
    PubMed     Abstract available

  15. GOODKIN DA, Zhao J, Cases A, Nangaku M, et al
    Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
    Am J Nephrol. 2022 Apr 22:1-10. doi: 10.1159/000523947.
    PubMed     Abstract available

  16. AGRAWAL D, Varade D, Shah H, Nazar A, et al
    Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND).
    Am J Nephrol. 2022 Apr 22:1-9. doi: 10.1159/000523961.
    PubMed     Abstract available

  17. GANG S, Khetan P, Varade D, Chinta VR, et al
    Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D).
    Am J Nephrol. 2022 Apr 22:1-9. doi: 10.1159/000523949.
    PubMed     Abstract available

  18. KIM DH, Park HC, Cho A, Kim J, et al
    Nurse Caseload and Patient Survival in Hemodialysis Units: A Korean Nationwide Cohort Study.
    Am J Nephrol. 2022 Apr 20:1-9. doi: 10.1159/000524110.
    PubMed     Abstract available

    March 2022
  19. GOLLIE JM, Patel SS, Harris-Love MO, Cohen SD, et al
    Fatigability and the Role of Neuromuscular Impairments in Chronic Kidney Disease.
    Am J Nephrol. 2022 Mar 28:1-11. doi: 10.1159/000523714.
    PubMed     Abstract available

  20. BLEYER AJ, Westemeyer M, Xie J, Bloom MS, et al
    Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel.
    Am J Nephrol. 2022 Mar 24:1-10. doi: 10.1159/000522226.
    PubMed     Abstract available

  21. SCHREIER DJ, Rule AD, Kashani KB, Mara KC, et al
    Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors.
    Am J Nephrol. 2022 Mar 16:1-9. doi: 10.1159/000522139.
    PubMed     Abstract available

  22. OKUBO A, Doi T, Morii K, Nishizawa Y, et al
    Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2022 Mar 8:1-7. doi: 10.1159/000522225.
    PubMed     Abstract available

    February 2022
  23. SOOHOO M, Obi Y, Rivara MB, Adams SV, et al
    Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism.
    Am J Nephrol. 2022 Feb 28:1-12. doi: 10.1159/000521508.
    PubMed     Abstract available

  24. FUJII N, Hamano T, Hsu JY, Imai E, et al
    A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
    Am J Nephrol. 2022 Feb 28:1-14. doi: 10.1159/000521386.
    PubMed     Abstract available

  25. TSAI HC, Ou SM, Wu CC, Huang CC, et al
    Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients.
    Am J Nephrol. 2022 Feb 25:1-9. doi: 10.1159/000522049.
    PubMed     Abstract available

  26. ZHANG J, Fuhrer T, Ye H, Kwan B, et al
    High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Am J Nephrol. 2022 Feb 23:1-11. doi: 10.1159/000521940.
    PubMed     Abstract available

  27. SHASHAR M, Nacasch N, Grupper A, Benchetrit S, et al
    Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.
    Am J Nephrol. 2022 Feb 16:1-8. doi: 10.1159/000521676.
    PubMed     Abstract available

  28. VARETA G, Georgianos PI, Vaios V, Sgouropoulou V, et al
    Epidemiology of Hypertension among Patients on Peritoneal Dialysis Using Standardized Office and Ambulatory Blood Pressure Recordings.
    Am J Nephrol. 2022 Feb 4:1-9. doi: 10.1159/000521861.
    PubMed     Abstract available

    January 2022
  29. BENMIRA AM, Moranne O, Prelipcean C, Pambrun E, et al
    Direct Determination rather than Oscillometric Estimation of Systolic Blood Pressure in Patients with Severe Chronic Kidney Disease.
    Am J Nephrol. 2022 Jan 12:1-9. doi: 10.1159/000520996.
    PubMed     Abstract available

  30. BHANDARI SK, Zhou H, Shaw SF, Shi J, et al
    Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System.
    Am J Nephrol. 2022 Jan 11:1-9. doi: 10.1159/000520466.
    PubMed     Abstract available

  31. ZHU B, Liu WH, Lin Y, Li Q, et al
    Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Am J Nephrol. 2022;53:455-469.
    PubMed     Abstract available

    December 2021
  32. DIAMANTIDIS CJ, Zepel L, Wang V, Smith VA, et al
    Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees.
    Am J Nephrol. 2021;52:949-957.
    PubMed     Abstract available

  33. YOU HS, Shin SJ, Kim J, Kang HT, et al
    Statin Use and Incidence of Chronic Kidney Disease in Hypercholesterolemia Patients with Normal Renal Function.
    Am J Nephrol. 2021 Dec 3:1-9. doi: 10.1159/000520532.
    PubMed     Abstract available

    November 2021
  34. OTOBE Y, Yamada M, Hiraki K, Onari S, et al
    Physical Exercise Improves Cognitive Function in Older Adults with Stage 3-4 Chronic Kidney Disease: A Randomized Controlled Trial.
    Am J Nephrol. 2021 Nov 30:1-11. doi: 10.1159/000520230.
    PubMed     Abstract available

  35. PAIK JM, Zhuo M, York C, Tsacogianis T, et al
    Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017.
    Am J Nephrol. 2021 Nov 23:1-10. doi: 10.1159/000520028.
    PubMed     Abstract available

  36. THOMSON BKA, Pilkey NG, Monteith B, Holden RM, et al
    A Scoping Review of Alternative Anticoagulation Strategies for Hemodialysis Patients with a Mechanical Heart Valve.
    Am J Nephrol. 2021;52.
    PubMed     Abstract available

  37. WEE HN, Liu JJ, Ching J, Kovalik JP, et al
    The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease.
    Am J Nephrol. 2021 Nov 9:1-17. doi: 10.1159/000519811.
    PubMed     Abstract available

  38. HU S, Wang D, Ma T, Yuan F, et al
    Association between Preoperative Monocyte-to-Lymphocyte Ratio and Late Arteriovenous Fistula Dysfunction in Hemodialysis Patients: A Cohort Study.
    Am J Nephrol. 2021 Nov 8:1-7. doi: 10.1159/000519822.
    PubMed     Abstract available

    October 2021
  39. JELANI QU, Llanos-Chea F, Bogra P, Trejo-Paredes C, et al
    Guideline-Directed Medical Therapy in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Intervention.
    Am J Nephrol. 2021 Oct 27:1-9. doi: 10.1159/000519484.
    PubMed     Abstract available

  40. GOLDBERG A, Garcia-Arroyo F, Sasai F, Rodriguez-Iturbe B, et al
    Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
    Am J Nephrol. 2021 Oct 21:1-8. doi: 10.1159/000519491.
    PubMed     Abstract available

  41. SELLIER AB, Seiler-Mussler S, Emrich IE, Bohm M, et al
    FGFR4 and Klotho Polymorphisms Are Not Associated with Cardiovascular Outcomes in Chronic Kidney Disease.
    Am J Nephrol. 2021 Oct 21:1-9. doi: 10.1159/000519274.
    PubMed     Abstract available

    September 2021
  42. EREZ D, Fanadka F, Benchetrit S, Cohen-Hagai K, et al
    The Combined Prognostic Significance of Alkaline Phosphatase and Intracranial Arterial Calcifications in Hemodialysis Patients.
    Am J Nephrol. 2021 Sep 17:1-7. doi: 10.1159/000518399.
    PubMed     Abstract available

  43. THEOFILIS P, Vordoni A, Koukoulaki M, Vlachopanos G, et al
    Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives.
    Am J Nephrol. 2021 Sep 17:1-9. doi: 10.1159/000518456.
    PubMed     Abstract available

  44. CIARDULLO S, Ballabeni C, Trevisan R, Perseghin G, et al
    Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease.
    Am J Nephrol. 2021;52:666-672.
    PubMed     Abstract available

    January 2021
  45. RAJKUMAR T, Wong J, Harvey M, Weidersehn L, et al
    Comparison of Sampling Methods for International Normalized Ratio Monitoring in Haemodialysis Patients (INRHaemo Study).
    Am J Nephrol. 2021;52:17-25.
    PubMed     Abstract available

  46. SY J, Hsiung JT, Edgett D, Kalantar-Zadeh K, et al
    Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort.
    Am J Nephrol. 2021;52:199-208.
    PubMed     Abstract available

  47. SHESHADRI A, Kittiskulnam P, Delgado C, Sudore RL, et al
    Association of Cognitive Function Screening Results with Adherence and Performance in a Pedometer-Based Intervention.
    Am J Nephrol. 2021;52:420-428.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.